| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/29/2009 | US7595329 4-{[4-({[(3-isopropyl-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)carbonyl]amino}methyl)piperidin-1-yl]methyl}tetrahydro-2H-pyran-4-carboxylic acid; serotonin receptor agonist; gastroesophageal reflux disease, analgesic, cognition activator; less toxicity, good absorption, and metabolic stability |
| 09/29/2009 | US7595317 Antiarthritic agents; rheumatoid and osteoarthritis; corneal, epidermal, or gastric ulceration; tumor metastasis or invasion; periodontal disease; and bone disease; 4-[(2-methyl-4-quinolinyl)methoxy]-N-(1,3,5-trioxo-2,4-diazaspiro[5.5]undec-7-yl)benzamide trifluoroacetate, for example |
| 09/29/2009 | US7595316 2-(1-Cyclopentylpiperidin-4-yloxy)-5-(4-cyanophenyl)pyrimidine, for example; exhibits histamine receptor H3 antagonist or inverse agonist activity and is useful for the treatment and/or prevention of obesity, diabetes, hormonal secretion abnormality, sleep disorders |
| 09/29/2009 | US7595301 Staple type oligonucleotide and drug comprising the same |
| 09/29/2009 | US7595058 Chlamydia antigens and vaccine uses of the protein |
| 09/29/2009 | US7595044 Artery-and vein-specific proteins and uses therefor |
| 09/29/2009 | CA2498457C Composition for treating hemorrhoids |
| 09/29/2009 | CA2494601C N-substituted-1h-indol-5-propionic acid compounds as ppar agonists useful for the treatment of diabetes |
| 09/29/2009 | CA2457944C Polycyclic guanine phosphodiesterase v inhibitors |
| 09/29/2009 | CA2391085C Bis-basic compounds as tryptase inhibitors, processes for preparing them and their use as phamaceutical compositions |
| 09/29/2009 | CA2379560C Purine derivatives inhibitors of tyrosine protein kinase syk |
| 09/29/2009 | CA2375670C 5-phenyl-pyrimidine derivatives |
| 09/29/2009 | CA2349330C Nitrogen containing heterobicycles as factor xa inhibitors |
| 09/29/2009 | CA2348391C Chromenone and chromanone derivatives as integrin inhibitors |
| 09/29/2009 | CA2347105C Controlled-release pharmaceutical composition with gastric residence |
| 09/29/2009 | CA2334730C Novel cyclosporins |
| 09/29/2009 | CA2328280C Thienopyrimidines |
| 09/29/2009 | CA2318208C Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 09/29/2009 | CA2315647C Inhibition of p38 kinase activity using aryl and heteroaryl substituted heterocyclic ureas |
| 09/29/2009 | CA2311922C Thienopyrimidines |
| 09/29/2009 | CA2294812C Solid pharmaceutical composition containing benzofurane derivatives |
| 09/29/2009 | CA2259148C Solid oral dosage forms of valsartan |
| 09/29/2009 | CA2255171C 1,3,8-triaza-spiro[4,5]decan-4-on derivatives |
| 09/29/2009 | CA2184297C Recombinant viruses coding for a glutamate decarboxylase (gad) activity |
| 09/29/2009 | CA2176796C Substituted benzyloxycarbonylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 09/29/2009 | CA2100329C Methods for treating tumor necrosis factor mediated diseases |
| 09/24/2009 | WO2009117710A2 Methods of treating inflammation |
| 09/24/2009 | WO2009117706A2 Methods of treatment using anti-mif antibodies |
| 09/24/2009 | WO2009117421A2 Heterocyclic modulators of gpr119 for treatment of disease |
| 09/24/2009 | WO2009116896A1 Use of glutaric acid derivatives or the pharmaceutically acceptable salts thereof as anti-arrhythmic agents |
| 09/24/2009 | WO2009116848A1 Labisia pumila extracts for reducing the risk of cardiovascular diseases |
| 09/24/2009 | WO2009116774A2 Composition for treatment or prevention of restenosis |
| 09/24/2009 | WO2009116546A1 Excitatory chemical mediator and method for screening thereof |
| 09/24/2009 | WO2009116529A1 Polypeptide and pharmaceutical composition containing the polypeptide |
| 09/24/2009 | WO2009115906A2 An improved process for preparation of carvedilol involving halohydrin derivative |
| 09/24/2009 | WO2009115669A1 Combination of a sinusal if current inhibitor and a beta-blocker |
| 09/24/2009 | WO2009115665A1 5.6-bisaryl-2-pyridine-carboxamide derivatives, preparation thereof and therapeutic application thereof as antagonists for urotensine ii receptors |
| 09/24/2009 | WO2009115658A2 Use of a caspase-1 inhibitor for treating atherosclerotic plaque |
| 09/24/2009 | WO2009115465A1 Synthetic phosphodiester oligonucleotides and therapeutical uses thereof |
| 09/24/2009 | WO2009115301A1 Solid pharmaceutical composition comprising a non-peptide angiotensin ii receptor antagonist and a diuretic |
| 09/24/2009 | WO2009087212A3 Pyridine derivatives |
| 09/24/2009 | WO2009084040A4 Once a day formulation of angiotensin receptor blockers |
| 09/24/2009 | WO2009071586A3 3-(2,2,2-trimethylhydrazinium) propionate salts for treating ischemic heart disease |
| 09/24/2009 | WO2009066315A3 Sustained release compositions of trimetazidine and process for preparation thereof |
| 09/24/2009 | WO2009061852A3 Modulation of factor 9 expression |
| 09/24/2009 | WO2009061807A3 Activin receptor-like kinase-i antagonist compositions and methods of use |
| 09/24/2009 | WO2009053443A3 Indane compounds |
| 09/24/2009 | WO2009040068A3 Use of a peptide as a therapeutic agent |
| 09/24/2009 | WO2009040067A3 Use of a peptide as a therapeutic agent |
| 09/24/2009 | WO2009040049A3 Use of acetyl- (ala10, 11)-rantes (1-14) and/or calcitonin as anti-angiogenic agents |
| 09/24/2009 | WO2009035949A3 Soluble epoxide hydrolase inhibitors |
| 09/24/2009 | WO2009033681A3 Cyclo-argd as a therapeutic agent |
| 09/24/2009 | WO2009033680A3 Galanin-like peptide alone or in combination with cyclo-argd as a therapeutic agent |
| 09/24/2009 | WO2009027077A3 5-arylalkylidene-2-arylalkyl-thiazol-4-one derivatives as inhibitors of 5-lipoxygenase and uses thereof |
| 09/24/2009 | WO2008065636A3 Treatment of disease by modulating cf5 protein |
| 09/24/2009 | US20090240053 2-(4-(1-methyl-4-piperidinoxy)benzylamino)-2-methyl-propanamide; nervous system disorders; analgesics; anticonvulsants; sodium channel moderators; antidepressants, antiarrhythmics and for the treatment or prevention of diabetic neuropathy |
| 09/24/2009 | US20090240051 New process for the production of oxabispidines |
| 09/24/2009 | US20090239938 Preventive/remedy for arteriosclerosis |
| 09/24/2009 | US20090239927 Statin and Omega-3 Fatty Acids For Lipid Therapy |
| 09/24/2009 | US20090239917 Heterocyclic Cycloalkyl Compounds, a Process for their Preparation and Pharmaceutical Compositions Containing Them |
| 09/24/2009 | US20090239915 Substituted 2-phenyl-benzimidazoles and their use as pharmaceuticals |
| 09/24/2009 | US20090239910 Benzenesulfonamide Compounds and Their Use |
| 09/24/2009 | US20090239883 Treatment of Pulmonary Hypertension |
| 09/24/2009 | US20090239879 N-oxides of n-phenyl-2-pyrimidine-amine derivatives |
| 09/24/2009 | US20090239865 Dibenzyl amine compounds and derivatives |
| 09/24/2009 | US20090239852 Use of oxicam compounds |
| 09/24/2009 | US20090239845 Pyrazole compounds as prostaglandin receptors ligands |
| 09/24/2009 | US20090239844 Ace inhibitor-vasopressin antagonist combinations |
| 09/24/2009 | US20090239839 Receptor antagonist |
| 09/24/2009 | US20090239827 Compounds having lipid lowering properties |
| 09/24/2009 | US20090239805 Human 3 relaxin |
| 09/24/2009 | US20090239801 Modified Fusion Polypeptides |
| 09/24/2009 | US20090239295 Dedifferentiated, Programmable Stem Cells of Monocytic Origin, and Their Production and Use |
| 09/24/2009 | US20090239227 Method of diagnosing risk of myocardial infarction |
| 09/24/2009 | US20090238903 Process for the preparation of sour cherry seed extract, use of the extract for the preparation of pharmaceutical compositions and pharmaceutical compositions containing said extract |
| 09/24/2009 | US20090238886 Retro-Inversion Peptides That Target GIT Transport Receptors and Related Methods |
| 09/24/2009 | US20090238854 Plasticizers for coating compositions |
| 09/24/2009 | US20090238838 Insulinotropic peptide conjugate using an immunoglobulin fc |
| 09/24/2009 | US20090238826 Inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumor formation and/or vascular leakage |
| 09/24/2009 | US20090238803 Human cord blood derived unrestricted somatic stem cells (ussc) |
| 09/24/2009 | US20090238801 Amnion-derived stem cells and uses thereof |
| 09/24/2009 | US20090238763 High penetration compositions and uses thereof |
| 09/24/2009 | US20090238756 Image-guided therapy of myocardial disease: composition, manufacturing and applications |
| 09/24/2009 | DE102008014855A1 Use of formulations for treating pathological vascular calcification occurring in renal disease, where the formulation contains trimagnesium dicitrate and/or trimagnesium diisocitrate as hydrate/anhydrate form |
| 09/24/2009 | CA2717365A1 Methods of treating inflammation |
| 09/24/2009 | CA2717071A1 Methods of treatment using anti-mif antibodies |
| 09/24/2009 | CA2715350A1 Solid pharmaceutical composition comprising a non-peptide angiotensin ii receptor antagonist and a diuretic |
| 09/24/2009 | CA2715096A1 5.6-bisaryl-2-pyridine-carboxamide derivatives, preparation thereof and therapeutic application thereof as antagonists for urotensine ii receptors |
| 09/24/2009 | CA2712705A1 Synthetic phosphodiester oligonucleotides and therapeutical uses thereof |
| 09/23/2009 | EP2103689A1 Synthetic phosphodiester oligonucleotides and therapeutical uses thereof |
| 09/23/2009 | EP2103630A1 Preparation of low bleeding anticoagulant fusion protein and its use |
| 09/23/2009 | EP2103613A1 Quinoxaline derivative |
| 09/23/2009 | EP2103610A1 The salts of imidazol-5-carboxylic acid derivatives, preparation methods and use therrof |
| 09/23/2009 | EP2103607A1 1-phenyl 1-thio-d-glucitol derivative |
| 09/23/2009 | EP2103598A1 Fluorinated cycloalkyl-derived benzoylguanidine, method for producing same, use of same as medicine and medicine containing same |
| 09/23/2009 | EP2102228A1 Method of diagnosing pre-eclampsia |
| 09/23/2009 | EP2102207A1 Spiro-piperidine derivatives as via receptor antagonists |
| 09/23/2009 | EP2102187A1 Substituted isoquinoline and isoquinolinone derivatives as inhibitors of rho-kinase |
| 09/23/2009 | EP2102185A1 Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2h-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor |
| 09/23/2009 | EP2102164A1 Cycloalkylamine substituted isoquinoline and isoquinolinone derivatives |